Back to Search
Start Over
Modeling Immune Evasion and Vaccine Limitations by Targeted Nasopharyngeal Bordetella pertussis Inoculation in Mice
- Source :
- Emerging Infectious Diseases, Emerging Infectious Diseases, Vol 27, Iss 8, Pp 2107-2116 (2021)
- Publication Year :
- 2021
- Publisher :
- Centers for Disease Control and Prevention (CDC), 2021.
-
Abstract
- Conventional pertussis animal models deliver hundreds of thousands of Bordetella pertussis bacteria deep into the lungs, rapidly inducing severe pneumonic pathology and a robust immune response. However, human infections usually begin with colonization and growth in the upper respiratory tract. We inoculated only the nasopharynx of mice to explore the course of infection in a more natural exposure model. Nasopharyngeal colonization resulted in robust growth in the upper respiratory tract but elicited little immune response, enabling prolonged and persistent infection. Immunization with human acellular pertussis vaccine, which prevents severe lung infections in the conventional pneumonic infection model, had little effect on nasopharyngeal colonization. Our infection model revealed that B. pertussis can efficiently colonize the mouse nasopharynx, grow and spread within and between respiratory organs, evade robust host immunity, and persist for months. This experimental approach can measure aspects of the infection processes not observed in the conventional pneumonic infection model.
- Subjects :
- Microbiology (medical)
Bordetella pertussis
Whooping Cough
Epidemiology
Infectious and parasitic diseases
RC109-216
Targeted Nasopharyngeal Bordetella pertussis Inoculation in Mice Reveals Immune Evasion and Models Vaccine Limitations
respiratory infections
Mice
Immune system
Nasopharynx
Animals
Medicine
Colonization
Respiratory system
bacteria
asymptomatic infection
Bordetella Infections
Immune Evasion
Pertussis Vaccine
Lung
biology
business.industry
Research
vaccines
biology.organism_classification
medicine.disease
Infectious Diseases
medicine.anatomical_structure
Upper respiratory tract infection
upper respiratory tract infection
Immunization
Immunology
business
Respiratory tract
Subjects
Details
- ISSN :
- 10806059 and 10806040
- Volume :
- 27
- Database :
- OpenAIRE
- Journal :
- Emerging Infectious Diseases
- Accession number :
- edsair.doi.dedup.....fa4725d365f6a3bf11ee0387fdf20d21